Neotiv develops a digital platform that incorporates unique cognitive tests for the early assessment and longitudinal monitoring of memory problems associated with Alzheimer's disease. The platform enables researchers and healthcare providers to customize study designs and track cognitive performance over time, enhancing diagnostic accuracy and patient care.
Funding
$9.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Early detection and monitoring of memory problems associated with Alzheimer's disease rely on traditional cognitive assessments, which can be time-consuming, require specialized training, and may not be easily accessible for frequent, longitudinal tracking. This can lead to delays in diagnosis and intervention, hindering effective patient care and research efforts.
Solution
Neotiv provides a digital platform featuring cognitive tests designed for the early assessment and longitudinal monitoring of memory problems related to Alzheimer's disease. The platform offers customizable study designs and tracks cognitive performance over time through an intuitive graphical user interface. The tests are easy to understand and involve memorizing and remembering visual information, enabling the tracking of memory performance over time. The platform supports mobile or on-site assessments, facilitating use in research, diagnosis support, and drug development.
Target Audience
The primary users are scientists, clinical researchers, and physicians involved in Alzheimer's disease research, diagnosis, and patient care.
Features
- Customizable study designs through the neotivTrials web portal
- Easy-to-understand tests involving memorizing and remembering visual information
- Longitudinal tracking of memory performance
- Customizable health questionnaires and adapted versions of established neuropsychological tests
- Mobile and on-site assessment capabilities
- Focus on different anatomical pathways for increased diagnostic and monitoring possibilities